Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Rachel Howard
  • October 13, 2020
  • Events

World Pharma Pricing Market Access & Evidence Congress 2020

World Pharma Pricing Market Access & Evidence Congress 2020

Last month, several members of Research Partnership’s specialist market access team, including Directors Brett Gardiner and Rachel Howard, attended the virtual World Pharma Pricing Market Access & Evidence Congress.

This two-and-a-half day online event brought together over 1,000 stakeholders from the pharma and biotech industry with HTAs, payers and solution providers from across the globe.

read more »

  • Posted by Brett Gardiner
  • September 30, 2020
  • Webinars

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Our market access team share insights from our COVID-19 impact study and advise how biopharmaceutical companies can keep up with pricing and market access activity.

COVID-19 is causing major disruption to healthcare systems all over the world and in these difficult times it’s hard to keep up with all of the latest developments. With the landscape changing almost every day, how can we tell what impact coronavirus is really having?
 

read more »

How we used our proprietary ChoiceQual conjoint technique to assess and develop a market access and pricing strategy for an influenza vaccine

How we used our proprietary ChoiceQual conjoint technique to assess and develop a market access and pricing strategy for an influenza vaccine

Our client required pricing research to better inform their pricing and access strategy for their influenza vaccine product. They wanted to understand how the attributes for Product X may or may not drive a price premium across a range of geographies and how future positioning and real world evidence availability might impact price and willingness to pay (WTP).

read more »

  • Posted by Suzan Serip, Artemis Rizoglou, Brett Gardiner
  • August 4, 2020
  • Articles

The race to secure a SARS-CoV-2 vaccine: big promises linked to big(ger) deals

The race to secure a SARS-CoV-2 vaccine: big promises linked to big(ger) deals

Market Access Director Brett Gardiner, Consultant Suzan Serip and Analyst Artemis Rizoglou explore the various SARS-CoV-2 vaccine supply deals that have been struck around the world.

As clinical trials for SARS-CoV-2 vaccines are still ongoing and final results are not expected until earlier than this autumn, in recent months we have witnessed an increasing amount of supply deals between governments and vaccine manufacturers.

read more »

  • Posted by George Forsyth
  • July 27, 2020
  • Articles

How will COVID-19 affect the financing of healthcare provision across the US?

How will COVID-19 affect the financing of healthcare provision across the US?

Using findings from our syndicated study to assess the impact of COVID-19 on biopharmaceutical market access, Senior Consultant George Forsyth explores the economic impact to the US healthcare system. Published by Pharma Exec in June 2020.

The current coronavirus pandemic sweeping across the globe represents one of the greatest fiscal challenges to US healthcare policymakers in modern times. The Federal Reserve expects the US economy to contract by a staggering 6.5% this year, with approximately 20 million Americans unemployed and many more without medical insurance. 

read more »